Heterozygous Carriage of a Dysfunctional Toll-like Receptor 9 Allele Affects CpG Oligonucleotide Responses in B Cells (CROSBI ID 188215)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Knežević, Jelena ; Pavlinić, Dinko ; Rose, William II ; Leifer, Cynthia A. ; Bendelja, Krešo ; Gabrilovac, Jelka ; Parčina, Marijo ; Lauc, Gordan ; Kubarenko, Andriy V. ; Petričević, Branka ; Vrbanec, Damir ; Bulat-Kardum, Ljiljana ; Bekeredjian-Ding, Isabelle ; Pavelić, Jasminka ; Dembić, Zlatko ; Weber, ALexander N.R.
engleski
Heterozygous Carriage of a Dysfunctional Toll-like Receptor 9 Allele Affects CpG Oligonucleotide Responses in B Cells
Toll-like receptors (TLR) are employed by the innate immune system to detect microbial pathogens based on conserved microbial pathogen molecules. For example, TLR9 is a receptor for CpG-containing microbial DNA, and its activation results in the production of cytokines and type I interferons from human B cells and plasmacytoid dendritic cells, respectively. Both are required for mounting an efficient antibacterial or antiviral immune response. These effects are mimicked by synthetic CpG oligodeoxynucleotides (ODN). Although several hyporesponsive TLR9 variants have been reported, their functional relevance in human primary cells has not been addressed. Here we report a novel TLR9 allele, R892W, which is hyporesponsive to CpG ODN and acts as a dominant-negative in a cellular model system. The R892W variant is characterized by increased MyD88 binding and defective co-localization with CpG ODN. Whereas primary plasmacytoid dendritic cells isolated from a heterozygous R892W carrier responded normally to CpG by interferon-alpha production, carrier B cells showed impaired IL-6 and IL-10 production. This suggests that heterozygous carriage of a hyporesponsive TLR9 allele is not associated with complete loss of TLR9 function but that TLR9 signals elicited in different cell types are regulated differently in human primary cells.
novel TLR9 allele; B cells; defective IL-6 and IL-10 production
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
287 (29)
2012.
24544-24553
objavljeno
0021-9258
10.1074/jbc.M111.337477
Povezanost rada
Temeljne medicinske znanosti, Kliničke medicinske znanosti